Diagnosis and Management of Ductal Carcinoma in Situ (DCIS) – September 2009

Posted on November 10, 2009. Filed under: Oncology | Tags: |

Virnig BA, Shamliyan T, Tuttle TM, Kane RL, and Wilt TJ. Diagnosis and Management of Ductal Carcinoma in Situ (DCIS). Evidence Report/Technology Assessment No. 185 (Prepared by the Minnesota Evidence-based Practice Center under Contract No. 290-02-10064-I). AHRQ Publication No.09-E018. Rockville, MD. Agency for Healthcare Research and Quality. September 2009.

“AHRQ has released a new evidence report that found the incidence of ductal carcinoma in situ—the most common type of breast cancer—has continued to increase in the post-mammography era.  Researchers led by Beth A. Virnig, Ph.D., M.P.H., identified the need to better understand whether it is possible to modify current imaging technologies or screening guidelines to more effectively identify lesions that are unlikely to become clinically problematic, as well as tumors that are likely to contain some invasive component.  While evidence supports treating ductal carcinoma in situ, ongoing trials are exploring the best clinical strategy for treating ductal carcinoma in situ.  The report, Diagnosis and Management of Ductal Carcinoma in Situ, was conducted by AHRQ’s Minnesota University Evidence-based Practice Center and was requested and funded by the NIH’s Office of Medical Applications of Research, for a State-of-the-Science Conference on the topic on September 22-24, 2009.”


Make a Comment

Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

Liked it here?
Why not try sites on the blogroll...

%d bloggers like this: